189 Epizód

  1. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the Netherlands and the United Kingdom

    Közzétéve: 2020. 11. 20.

  2. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France

    Közzétéve: 2020. 11. 19.

  3. Molecular Classification of Endometrial Carcinoma in the Clinic Today

    Közzétéve: 2020. 11. 11.

  4. Advances in Immunotherapy for Endometrial Cancer

    Közzétéve: 2020. 11. 11.

  5. Developments in Acute Leukemias: Expert Answers to Clinician Questions

    Közzétéve: 2020. 10. 02.

  6. Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy

    Közzétéve: 2020. 10. 02.

  7. Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond

    Közzétéve: 2020. 10. 02.

  8. Experts Discuss Evolving State-of-the-Art Management of Patients With HER2-Positive MBC

    Közzétéve: 2020. 09. 21.

  9. The Art of Medicine: Clinical Considerations for Patients With Advanced RCC

    Közzétéve: 2020. 09. 21.

  10. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1

    Közzétéve: 2020. 09. 17.

  11. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3

    Közzétéve: 2020. 09. 17.

  12. Clinical Considerations for <em>RET</em> Fusion–Positive NSCLC

    Közzétéve: 2020. 09. 17.

  13. Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2

    Közzétéve: 2020. 09. 16.

  14. CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions

    Közzétéve: 2020. 09. 14.

  15. Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond

    Közzétéve: 2020. 09. 08.

  16. FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma

    Közzétéve: 2020. 09. 03.

  17. New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments

    Közzétéve: 2020. 09. 01.

  18. Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy

    Közzétéve: 2020. 08. 31.

  19. Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma

    Közzétéve: 2020. 08. 31.

  20. MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1

    Közzétéve: 2020. 08. 28.

9 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site